Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms
- PMID: 33451899
- PMCID: PMC8273187
- DOI: 10.1016/j.jcf.2020.12.021
Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms
Abstract
Background: Gastrointestinal (GI) involvement among persons with cystic fibrosis (CF) is highly prevalent, representing a significant source of morbidity. Persons with CF have identified GI concerns as a top research priority, yet universal clinical outcome measures capturing many of the GI symptoms experienced in CF are lacking. The GALAXY study was envisioned to address this unmet need.
Methods: The GALAXY study team partnered with Community Voice, a community of patients with CF and their caregivers, to identify the patient reported outcome measures that most accurately reflected their experience with GI symptoms in CF. We also surveyed CF care teams to identify the comfort level of various team members (providers, nurses and dieticians) in managing a variety of GI conditions.
Results: Members of Community Voice identified the combination of PAC-SYM, PAGI-SYM, PAC-QOL and the Bristol Stool scale with three additional symptom-specific questions as patient-reported outcome measures that comprehensively captured the CF experience with GI disease. CF care team providers reported a high level of comfort in treating GI conditions including constipation (92%), GERD (93%), and gassiness (77%), however comfort level was limited to only first-line interventions.
Conclusion: By partnering with persons with CF as well as their caregivers and medical providers, the GALAXY study is designed to uniquely capture the prevalence and severity of GI involvement among persons with CF in a manner that reflects the CF patient experience. The results of GALAXY will inform the development of future interventional trials and serve as a reproducible and objective study endpoint.
Keywords: Community Involvement; Gastrointestinal; Patient reported outcome measures (proms).
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Each of the authors have funding through Cystic Fibrosis Foundation (CFF) with five of the authors employed by the CFF (EA, DB, DR.., CR and CUF). The authors have no other conflicts of interest related to this manuscript.
Comment in
-
Cystic Fibrosis Related Gastrointestinal Manifestations - Moving Forward.J Cyst Fibros. 2021 Jul;20(4):562-563. doi: 10.1016/j.jcf.2021.07.011. J Cyst Fibros. 2021. PMID: 34452731 No abstract available.
Similar articles
-
Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis.J Cyst Fibros. 2023 Mar;22(2):266-274. doi: 10.1016/j.jcf.2022.10.006. Epub 2022 Oct 29. J Cyst Fibros. 2023. PMID: 36319569 Free PMC article.
-
Estimating minimal clinically important difference (MCID) for gastrointestinal symptoms in cystic fibrosis.J Cyst Fibros. 2024 Sep;23(5):991-999. doi: 10.1016/j.jcf.2024.07.013. Epub 2024 Jul 23. J Cyst Fibros. 2024. PMID: 39048465
-
Utilization of electronic patient-reported outcome measures in cystic fibrosis research: Application to the GALAXY study.J Cyst Fibros. 2021 Jul;20(4):605-611. doi: 10.1016/j.jcf.2021.07.002. Epub 2021 Jul 22. J Cyst Fibros. 2021. PMID: 34305007 Free PMC article.
-
Gastrointestinal and Hepatobiliary Disease in Cystic Fibrosis.Semin Respir Crit Care Med. 2019 Dec;40(6):825-841. doi: 10.1055/s-0039-1697591. Epub 2019 Oct 28. Semin Respir Crit Care Med. 2019. PMID: 31659728 Review.
-
Scoring Abdominal Symptoms in People with Cystic Fibrosis.J Clin Med. 2024 Mar 13;13(6):1650. doi: 10.3390/jcm13061650. J Clin Med. 2024. PMID: 38541878 Free PMC article. Review.
Cited by
-
Presentation, characteristics and management of obstructive intestinal conditions in cystic fibrosis.Frontline Gastroenterol. 2024 Jan 6;15(3):222-227. doi: 10.1136/flgastro-2023-102533. eCollection 2024 May. Frontline Gastroenterol. 2024. PMID: 38665789 Free PMC article.
-
The current state of gastrointestinal motility evaluation in cystic fibrosis: a comprehensive literature review.Transl Gastroenterol Hepatol. 2023 Dec 6;9:10. doi: 10.21037/tgh-23-59. eCollection 2024. Transl Gastroenterol Hepatol. 2023. PMID: 38317748 Free PMC article. Review.
-
Pancreatic, nutritional and clinical outcomes in children 0-5 years with cystic fibrosis during the first 2 years of CFTR modulator therapy (PaNC): a multicentre prospective observational study protocol.BMJ Open. 2025 Jul 30;15(7):e097071. doi: 10.1136/bmjopen-2024-097071. BMJ Open. 2025. PMID: 40738633 Free PMC article.
-
Association between stool consistency and clinical variables among infants with cystic fibrosis: Findings from the BONUS study.J Cyst Fibros. 2022 Sep;21(5):830-836. doi: 10.1016/j.jcf.2022.05.003. Epub 2022 May 16. J Cyst Fibros. 2022. PMID: 35585010 Free PMC article.
-
Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis.J Cyst Fibros. 2023 Mar;22(2):266-274. doi: 10.1016/j.jcf.2022.10.006. Epub 2022 Oct 29. J Cyst Fibros. 2023. PMID: 36319569 Free PMC article.
References
-
- Hollin IL, Donaldson SH, Roman C, Aliaj E, Riva D, Boyle M, Borowitz D: Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community. J Cyst Fibros 2019, 18(3):375–377. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical